Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
Authors
Keywords
-
Journal
DIABETES
Volume 64, Issue 2, Pages 587-592
Publisher
American Diabetes Association
Online
2014-09-10
DOI
10.2337/db14-0656
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progress in immune-based therapies for type 1 diabetes
- (2013) M. von Herrath et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Mesenchymal Stem Cells in Tissue Repair
- (2013) Amy M. DiMarino et al. Frontiers in Immunology
- Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data
- (2012) C. J. Greenbaum et al. DIABETES
- Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study
- (2012) D. Dabelea et al. DIABETOLOGIA
- Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
- (2012) Guido Moll et al. STEM CELLS
- Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
- (2012) L. von Bahr et al. STEM CELLS
- Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
- (2011) Lena von Bahr et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes
- (2010) M. Jurewicz et al. DIABETES
- Mesenchymal Stem Cells Inhibit Human Th17 Cell Differentiation and Function and Induce a T Regulatory Cell Phenotype
- (2010) S. Ghannam et al. JOURNAL OF IMMUNOLOGY
- Persistent High Glucose Concentrations Alter the Regenerative Potential of Mesenchymal Stem Cells
- (2010) Christopher Cramer et al. STEM CELLS AND DEVELOPMENT
- Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and -9
- (2009) Y. Ding et al. DIABETES
- Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
- (2009) P. Fiorina et al. JOURNAL OF IMMUNOLOGY
- Immunomodulation by Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Type 1 Diabetes
- (2008) R. Abdi et al. DIABETES
- Mesenchymal cells recruit and regulate T regulatory cells
- (2008) M DIIANNI EXPERIMENTAL HEMATOLOGY
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
- (2008) Katarina Le Blanc et al. LANCET
- The Anti-Inflammatory and Anti-Angiogenic Role of Mesenchymal Stem Cells in Corneal Wound Healing Following Chemical Injury
- (2008) Joo Youn Oh et al. STEM CELLS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started